PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 6142577-5 1984 SS-14 had no significant effect on serum potassium or aldosterone but an equimolar dose of SS-28 significantly enhanced the rise in potassium and aldosterone. Potassium 132-141 somatostatin Homo sapiens 91-96 10854586-0 2000 Potassium depolarization-induced cAMP stimulates somatostatin mRNA levels in cultured diencephalic neurons. Potassium 0-9 somatostatin Homo sapiens 49-61 10854586-3 2000 We have previously demonstrated in fetal cerebrocortical cells, that somatostatin (SS) mRNA levels can be induced by depolarizing agents such as high potassium concentrations and veratridine (VTD), and that these effects are calcium dependent. Potassium 150-159 somatostatin Homo sapiens 69-81 10854586-3 2000 We have previously demonstrated in fetal cerebrocortical cells, that somatostatin (SS) mRNA levels can be induced by depolarizing agents such as high potassium concentrations and veratridine (VTD), and that these effects are calcium dependent. Potassium 150-159 somatostatin Homo sapiens 83-85 1681489-3 1991 Somatostatin decreases the renal plasma flow, glomerular filtration rate, osmotic and free water clearances, sodium and potassium excretion and the tubular reabsorption of phosphorus while urinary osmolality increases. Potassium 120-129 somatostatin Homo sapiens 0-12 1684641-3 1991 Suppression of insulin by somatostatin may have contributed to the hyperkalemia by impairing cellular potassium uptake. Potassium 102-111 somatostatin Homo sapiens 26-38 1968675-7 1990 It was evident that chronic exposure to high potassium concentrations modified the elution profile of medium IR-SRIF on HPLC and gel filtration, causing an increase in somatostatin-28 (S-28) and a decrease in somatostatin-14 (S-14). Potassium 45-54 somatostatin Homo sapiens 168-183 1968675-7 1990 It was evident that chronic exposure to high potassium concentrations modified the elution profile of medium IR-SRIF on HPLC and gel filtration, causing an increase in somatostatin-28 (S-28) and a decrease in somatostatin-14 (S-14). Potassium 45-54 somatostatin Homo sapiens 209-224 2456821-2 1988 Both the release of somatostatin and the increase in cyclic AMP elicited by VIP require exogenous calcium, can be blocked by cobalt ion, and can be qualitatively mimicked by depolarizating concentrations of exogenous potassium ion. Potassium 217-226 somatostatin Homo sapiens 20-32 12595961-0 2003 Somatostatin inhibits potassium-evoked glutamate release by activation of the sst(2) somatostatin receptor in the mouse retina. Potassium 22-31 somatostatin Homo sapiens 85-97 2892268-3 1988 Both somatostatin-28 and somatostatin-14 elicited a steady outward current and selectively augmented the noninactivating, voltage-dependent outward potassium current known as the M-current. Potassium 148-157 somatostatin Homo sapiens 5-20 2892268-3 1988 Both somatostatin-28 and somatostatin-14 elicited a steady outward current and selectively augmented the noninactivating, voltage-dependent outward potassium current known as the M-current. Potassium 148-157 somatostatin Homo sapiens 25-40 6142577-7 1984 Since insulin opposes the increase in serum potassium by stimulating cellular uptake of this cation, the enhanced rise in serum potassium in response to arginine hydrochloride during the SS-28 infusion is likely due to the potent insulin suppressing effect of SS-28. Potassium 128-137 somatostatin Homo sapiens 187-192 6142577-7 1984 Since insulin opposes the increase in serum potassium by stimulating cellular uptake of this cation, the enhanced rise in serum potassium in response to arginine hydrochloride during the SS-28 infusion is likely due to the potent insulin suppressing effect of SS-28. Potassium 128-137 somatostatin Homo sapiens 260-265 6143598-1 1984 The somatostatin content of the nucleus of the solitary tract (NTS) was regionally distributed within the nucleus and a calcium-dependent release of the neuropeptide was evoked by potassium-induced depolarization in vitro. Potassium 180-189 somatostatin Homo sapiens 4-16